Biology Reference
In-Depth Information
57. Huttunen HJ, Kuja-Panula J, Rauvala H. Receptor for advanced glycation end products
(RAGE) signaling induces CREB-dependent chromogranin expression during neuronal
differentiation. J Biol Chem 2002;277:38635-46.
58. Ishihara K, Tsutsumi K, Kawane S, Nakajima M, Kasaoka T. The receptor for advanced
glycation end-products (RAGE) directly binds to ERK by a D-domain-like docking site.
FEBS Lett 2003;550:107-13.
59. Kim KS, Kim HY, Joe EH, Jou I. Matrix metalloproteinase-3 induction in rat brain astro-
cytes: focus on the role of two AP-1 elements. Biochem J 2008;410:605-11.
60. Moynagh PN. The interleukin-1 signalling pathway in astrocytes: a key contributor to
inflammation in the brain. J Anat 2005;207:265-69.
61. Rouhiainen A, Tumova S, Valmu L, Kalkkinen N, Rauvala H. Pivotal advance: analysis
of proinflammatory activity of highly purified eukaryotic recombinant HMGB1 (amphot-
erin). J Leukoc Biol 2007;81:49-58.
62. Luo Y, Berman MA, Zhai Q, Fischer FR, Abromson-Leeman SR, Zhang Y, et al.
RANTES stimulates inflammatory cascades and receptor modulation in murine astrocytes.
Glia 2002;39:19-30.
63. Ambrosini E, Remoli ME, Giacomini E, Rosicarelli B, Serafini B, Lande R, et al.
Astrocytes produce dendritic cell-attracting chemokines
in vitro
and in multiple sclerosis
lesions. J Neuropathol Exp Neurol 2005;64:706-15.
64. Garcia-Ramallo E, Marques T, Prats N, Belata J, Kunkel SL, Godessart N. Resident cell
chemokine expression serves as the major mechanism for leukocyte recruitment during
local inflammation. J Immunol 2002;169:6467-73.
65. Tanuma N, Sakuma H, Sasaki A, Matsumoto Y. Chemokine expression by astrocytes
plays a role in microglia/macrophage activation and subsequent neurodegeneration in sec-
ondary progressive multiple sclerosis. Acta Neuropathol 2006;112:195-204.
66. Musante V, Longordo F, Neri E, Pedrazzi M, Kalfas F, Severi P, et al. RANTES modulates
the release of glutamate in human neocortex. J Neurosci 2008;47:12231-40.
67. Lu W, Maheshwari A, Misiuta I, Fox SE, Chen N, Zigova T, et al. Neutrophil-specific
chemokines are produced by astrocytic cells but not by neuronal cells. Brain Res Dev
Brain Res 2005;155:127-34.
68. Carlson T, Kroenke M, Rao P, Lane TE, Segal B. The Th17-ELR CXC chemokine path-
way is essential for the development of central nervous system autoimmune disease. J Exp
Med 2008;205:811-23.
69. Omari KM, John G, Lango R, Raine CS. Role for CXCR2 and CXCL1 on glia in multiple
sclerosis. Glia 2006;53:24-31.
70. Hulshof S, van Haastert ES, Kuipers HF, van den Elsen PJ, De Groot CJ, van der Valk P,
et al. CX3CL1 and CX3CR1 expression in human brain tissue: noninflammatory control
versus multiple sclerosis. J Neuropathol Exp Neurol 2003;62:899-907.
71. Milligan ED, Sloane EM, Watkins LR. Glia in pathological pain: a role for fractalkine.
J Neuroimmunol 2008;198:113-20.
72. Haskell CA, Cleary MD, Charo IF. Molecular uncoupling of fractalkine-mediated cell
adhesion and signal transduction. Rapid flow arrest of CX3CR1-expressing cells is inde-
pendent of G-protein activation. J Biol Chem 1999;274:10053-58.
73. Huang D, Shi FD, Jung S, Pien GC, Wang J, Salazar-Mather TP, et al. The neuronal
chemokine CX3CL1/fractalkine selectively recruits NK cells that modify experi-
mental autoimmune encephalomyelitis within the central nervous system. FASEB J
2006;20:896-905.
